Binge Eating: Biopsychosocial Etiology, Maintenance Cycles, and Clinical Implications

Binge eating—consuming an objectively large amount of food with a sense of loss of control—is a transdiagnostic symptom seen in binge-eating disorder (BED), bulimia nervosa, anorexia nervosa binge-purge subtype, and subthreshold presentations. It's not a failure of willpower; it's a complex biobehavioral syndrome with deep roots in neurobiology, psychology, environment, and development.

Biopsychosocial Etiology: Six Interlocking Domains

1. Neurobiological

  • Dopaminergic reward dysregulation: reduced D2 receptor availability, heightened cue reactivity to palatable food.
  • Opioid/endocannabinoid system involvement in hedonic ("pleasure-driven") eating.
  • Hypothalamic appetite circuits (NPY/AgRP orexigenic, POMC anorexigenic) disrupted by dieting/weight cycling.

2. Psychological

  • Emotion regulation deficits: binge as escape from negative affect (Heatherton & Baumeister's escape theory).
  • Overvaluation of shape/weight → dietary restraint → disinhibition (Polivy & Herman's restraint model).
  • Impulsivity, perfectionism, low self-esteem, trauma history (ACE score correlation).

3. Environmental / Sociocultural

  • Weight stigma, thin-ideal internalization, diet culture messaging.
  • Food environment: ultra-processed, hyper-palatable, ubiquitous, cheap.
  • Food insecurity → feast-famine cycles → binge phenotype.

4. Developmental

  • Childhood adversity (neglect, abuse, weight teasing) → 2–3× BED risk.
  • Early dieting (before age 14) predicts later binge pathology.

5. Genetic

  • Heritability ~45–55% for BED; shared genetic liability with obesity, ADHD, depression.
  • GWAS loci: FTO, DRD2, GRM7, CADM1—modest effect sizes, polygenic architecture.

6. Maintenance Cycles

Restrict → Crave → Binge → Shame → Restrict. This cycle self-perpetuates. Breaking it requires addressing both restriction and emotional triggers simultaneously—neither alone suffices.

Clinical Implications

  • Screen: BEDS-7 or SCOFF + binge module in primary care, OB/GYN, mental health.
  • Assess comorbidities: Mood, anxiety, ADHD, PTSD, substance use—high overlap.
  • Refer for evidence-based treatment: CBT-E (enhanced), IPT, DBT, lisdexamfetamine (only FDA-approved for BED), topiramate (off-label).
  • Weight-neutral / Health at Every Size®-aligned care improves engagement and outcomes.

Binge eating deserves compassionate, evidence-based intervention—not judgment. The neurobiology is real; the psychology is understandable; the recovery is possible.

Eating Disorders - Related Articles